230 Neuropathology providers practice across all 50 states and Washington DC, and 10% received drug or device company payments in 2025. New York has the most at 33. Listings are drawn from federal public records and are not endorsements.
Industry payment share ranges from 9% in New York to 4% in Texas, among states with 25 or more providers.
There are 230 Neuropathology providers with active NPI records across all 50 states and Washington DC, according to federal NPPES data refreshed monthly. New York has the most at 33.
23 of 230 Neuropathology providers nationally (10%) received at least one payment from a drug or device company in 2025, according to the federal Open Payments program. The share is highest in New York at 9% and lowest in Texas at 4%.
Provider counts come from the federal NPPES registry and CMS Doctors and Clinicians files. Payment figures come from the CMS Open Payments program for calendar year 2025. The directory refreshes monthly.
All specialties Ask Zach for help choosing